APA (7th ed.) Citation

AB, G., AB, L., M, S. J., A, I. R., N, M., J, C. M., . . . I, F. (2026). Atogepant for migraine in real-world clinical practice: Insights from a large multicentre study in a treatment-resistant population (GEMA project). Cephalalgia : an international journal of headache, 46(4), 3331024261431337. https://doi.org/10.1177/03331024261431337

Chicago Style (17th ed.) Citation

AB, Gago-Veiga, et al. "Atogepant for Migraine in Real-world Clinical Practice: Insights from a Large Multicentre Study in a Treatment-resistant Population (GEMA Project)." Cephalalgia : An International Journal of Headache 46, no. 4 (2026): 3331024261431337. https://doi.org/10.1177/03331024261431337.

MLA (9th ed.) Citation

AB, Gago-Veiga, et al. "Atogepant for Migraine in Real-world Clinical Practice: Insights from a Large Multicentre Study in a Treatment-resistant Population (GEMA Project)." Cephalalgia : An International Journal of Headache, vol. 46, no. 4, 2026, p. 3331024261431337, https://doi.org/10.1177/03331024261431337.